Teitz Awarded NIH R01 Grant

Tal TeitzTal Teitz, PhD, Department of Pharmacology and Neuroscience, was awarded a $2 million National Institutes of Health R01 grant for her project, “Repurposing an FDA approved Drug, B-Raf Kinase Inhibitor Dabrafenib for Protection from Cisplatin- and Noise- induced Hearing Loss.”